❭ Research by medical division ❭ Cancer Medicine ❭ Department of Oncology ❭ Urological oncology ❭ Research staff ❭
NameUnit(s)
Axcrona, UlrikaTesticular Cancer Research Group [Negaard]
Berner, KjetilUro-oncological Research Group [Lilleby]
Brabrand, SigmundUro-oncological Research Group [Lilleby]
Brennhovd, BjørnTesticular Cancer Research Group [Negaard]
Fedorcsak, PeterTesticular Cancer Research Group [Negaard]
Heck, AnsgarTesticular Cancer Research Group [Negaard]
Herlofson, Bente BrokstadUro-oncological Research Group [Lilleby]
Hodt, AndersTesticular Cancer Research Group [Negaard]
Iversen, Jon ReidarUro-oncological Research Group [Lilleby]
Katz, BetinaTesticular Cancer Research Group [Negaard]
Langberg, Carl W.Testicular Cancer Research Group [Negaard]
Larsen, Signe MelsenTesticular Cancer Research Group [Negaard]
Lilleby, WolfgangUro-oncological Research Group [Lilleby] ; Urological oncology
Negaard, Helene F. S.Testicular Cancer Research Group [Negaard]
Rogg, Lotte VictoriaUrological oncology
Rud, ErikTesticular Cancer Research Group [Negaard]
Russnes, Kjell MagneUro-oncological Research Group [Lilleby]
Skotheim, Rolf I.Testicular Cancer Research Group [Negaard]
Storås, Anne HolckUro-oncological Research Group [Lilleby]
Tafjord, GunnarUro-oncological Research Group [Lilleby]
Thon, KristianUro-oncological Research Group [Lilleby]
Wahlqvist, RolfTesticular Cancer Research Group [Negaard]
Scroll to top

Home Department of Oncology Urological oncology

  • Uro-oncology Research Group
  • Testicular Cancer Research Group
  • Research staff

Recent publications

Gerdtsson A, Torisson G, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2023)
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
BJU Int (in press)
DOI 10.1111/bju.16040, PubMed 37129962

Robsahm TE, Tsuruda KM, Hektoen HH, Storås AH, Cook MB, Hurwitz LM, Langseth H (2023)
Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway
Acta Oncol, 62 (1), 8-14
DOI 10.1080/0284186X.2023.2175331, PubMed 36762472

Lilleby W, Seierstad T, Inderberg EM, Hole KH (2023)
Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring
Int J Cancer, 152 (10), 2166-2173
DOI 10.1002/ijc.34448, PubMed 36715014

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Email: trond.olav.berg@rr-research.no

Cookie policy

Accessibility statement (in Norwegian)